During the past decade, III Oddzial Chorob Wewnetrznych Szpital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "III Oddzial Chorob Wewnetrznych Szpital" are "Asthma" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetes, Type 1" (1 trials) and "Diabetes, Type 2" (1 trials). Many other conditions were trialed in "III Oddzial Chorob Wewnetrznych Szpital" in a lesser frequency.

Most popular intervention types in "III Oddzial Chorob Wewnetrznych Szpital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Technosphere Insulin" (1 trials), "Technosphere® Insulin Inhalation Powder" (1 trials) and "Usual Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "III Oddzial Chorob Wewnetrznych Szpital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "III Oddzial Chorob Wewnetrznych Szpital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in III Oddzial Chorob Wewnetrznych Szpital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in III Oddzial Chorob Wewnetrznych Szpital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".